thyssenkrupp nucera AG & Co. KGaA/€NCH2
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About thyssenkrupp nucera AG & Co. KGaA
thyssenkrupp nucera AG & Co. KGaA specializes in the development, engineering, procurement, commissioning, and licensing of high-performance electrolysis technologies, focusing on green hydrogen, chlor-alkali, and hydrochloric acid solutions. Serving industries such as chemical manufacturing, steel production, and refineries, the company has completed over 600 electrolysis projects worldwide, totaling more than 10 gigawatts of installed capacity. Founded in 1960 and headquartered in Dortmund, Germany, thyssenkrupp nucera operates globally with locations in the United States, Italy, Saudi Arabia, Australia, China, and Japan. The company's strategic positioning is bolstered by its extensive experience in electrochemical plant construction and its commitment to advancing green hydrogen production technologies.
- Ticker
- €NCH2
- Sector
- Industrials
- Primary listing
- XETRA
- Employees
- 1,076
- Headquarters
- Dortmund, Germany
- Website
- thyssenkrupp-nucera.com
NCH2 Metrics
BasicAdvanced
€962M
-
-€0.50
1.13
-
Price and volume
Market cap
€962M
Beta
1.13
52-week high
€9.59
52-week low
€6.92
Average daily volume
45K
Financial strength
Current ratio
2.412
Quick ratio
1.917
Long term debt to equity
0.033
Total debt to equity
0.041
Profitability
EBITDA (TTM)
-61.8
Gross margin (TTM)
9.55%
Net profit margin (TTM)
-11.82%
Operating margin (TTM)
-13.15%
Effective tax rate (TTM)
-8.38%
Revenue per employee (TTM)
€500,000
Management effectiveness
Return on assets (TTM)
-3.72%
Return on equity (TTM)
-8.78%
Valuation
Price to revenue (TTM)
1.79
Price to book
1.39
Price to tangible book (TTM)
1.6
Price to free cash flow (TTM)
-32.873
Free cash flow yield (TTM)
-3.04%
Free cash flow per share (TTM)
-0.231
Growth
Revenue change (TTM)
-41.48%
Earnings per share change (TTM)
-486.59%
3-year revenue growth (CAGR)
-3.76%
3-year earnings per share growth (CAGR)
43.46%
What the Analysts think about NCH2
Analyst ratings (Buy, Hold, Sell) for thyssenkrupp nucera AG & Co. KGaA stock.
Analyst projections of the future price of thyssenkrupp nucera AG & Co. KGaA stock.
Bulls say / Bears say
Order intake nearly doubled to €471 million in the first nine months, including a 300 MW green-hydrogen award from Moeve in Spain. This suggests large projects are still moving into contracts, despite uneven timing between quarters. (thyssenkrupp nucera)
Chlor-alkali provides a profitable counterweight to weak hydrogen trading: nine-month order intake rose 32% and segment EBIT was €38 million. A further low-double-digit-million-euro order in China in September supports its established market position. (thyssenkrupp nucera, thyssenkrupp nucera)
Net financial assets of €627 million and a €638 million order backlog give the company financial room to manage losses and pursue new projects. The balance sheet provides a cushion while the hydrogen market develops. (thyssenkrupp nucera)
Management cut its 2025/26 EBIT outlook to a loss of €75 million–€105 million, from a previous loss range of €30 million–€80 million, and narrowed expected order intake to €550 million–€670 million. The revisions point to weaker near-term trading than previously expected. (Reuters)
Green-hydrogen sales fell to €80 million in the first nine months from €377 million a year earlier, while the segment’s EBIT loss widened to €107 million. Third-quarter hydrogen order intake was only €3 million, underlining the risk that major projects are not being replaced quickly enough. (thyssenkrupp nucera)
The second-quarter loss widened after higher costs on hydrogen projects and the termination of a US pilot project. The company’s hiring freeze and additional savings measures show that cost control remains a pressing issue as orders and project economics fluctuate. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 27 Oct 2026.
NCH2 Financial Performance
Revenues and expenses
NCH2 Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing NCH2
AllUSDEUR
Fund name | Fund size | €NCH2 weighting |
|---|---|---|
VanEck Hydrogen Economy$HDRO | $115M | 1.87% |
VanEck Hydrogen Economy£HDGB | $115M | 1.87% |
Xtrackers MSCI Europe Small Cap£XXSC | $3.6B | 0.02% |
Xtrackers MSCI Europe Small Cap€DX2J | $3.6B | 0.02% |
Vanguard Germany All Cap£VGER | €258M | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.